Here, by exploring vulnerabilities of human tumors that depend on mutant KRas, we sought to identify kinases and their corresponding pathways that mutant KRas depends on to induce malignant transformation and to target such pathways for cancer therapy. The gene discussed is KRAS; the disease is cancer.